Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|17|10|1057-1065

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.10, 2015-10, pp. : 1057-1065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using prophylactic proton pump inhibitor

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 478-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum tumour markers in patients with chronic kidney disease

By Xiaofang Y.   Yue Z.   Xialian X.   Zhibin Y.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 6, 2007-01 ,pp. : 661-667

Informa Healthcare

Access to resources Recommend Favorite

Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1201-1207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of High Thoracic Sympathetic Nerve Block on Serum Collagen Biomarkers in Patients with Chronic Heart Failure

By  

Cardiology, Vol. 136, Iss. 2, 2016-09 ,pp. : 102-107

Karger

Access to resources Recommend Favorite

Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function

By  

Cardiology, Vol. 130, Iss. 1, 2014-11 ,pp. : 17-22

Karger

Access to resources Recommend Favorite